Differential contribution of cholecystokinin receptors to stress-induced modulation of seizure and nociception thresholds in mice

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 2, 2004, Pages 209-215

  Homayoun, Houman ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antinociception; Cholecystokinin; Footshock stress; Opioid; Restraint stress; Seizure

Indexed keywords

CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; PENTETRAZOLE; PROGLUMIDE;

ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; SEIZURE; SHOCK; STRESS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; PAIN MEASUREMENT; PAIN THRESHOLD; PROGLUMIDE; RECEPTORS, CHOLECYSTOKININ; SEIZURES; STRESS;

EID: 3042683326     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.03.010     Document Type: Article

References (49)

1. Abelson J.L., Young E.A. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition. Psychoneuroendocrinology. 28:2003;169-180
2. A receptor binding in mouse forebrain membrane. Neurochem. Int. 31:1997;1-10
3. Bhatnagar S., Viau V., Chu A., Soriano L., Meijer O.C., Dallman M.F. A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J. Neurosci. 20:2000;5564-5573
4. Bhattacharya S.K., Keshary P.R., Sanyal A.K. Immobilisation stress-induced antinociception in rats: possible role of serotonin and prostaglandins. Eur. J. Pharmacol. 50:1978;83-85
5. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79
6. Dauge V., Pophillat M., Crete D., Melik-Parsadaniantz S., Roques B.P. Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory. Neuroscience. 118:2003;19-23
7. De-Lima T.C., Rae G.A. Effects of cold-restraint and swim stress on convulsions induced by pentylenetetrazole and electroshock: influence of naloxone pretreatment. Pharmacol. Biochem. Behav. 40:1991;297-300
8. Drugan R.C., McIntyre T.D., Alpern H.P., Maier S.F. Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. Brain Res. 342:1985;9-17
9. Eells J.B., Clough R.W., Browning R.A., Jobe P.C. Comparative FOS immunoreactivity in the brain after forebrain, brainstem or combined seizures induced by electroshock, pentylenetetrazole, focally induced and audiogenic seizures in rats. Neuroscience. 123:2004;279-292
10. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.A. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312
11. Friedrich A.E., Gebhart G.F. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat. J. Pharmacol. Exp. Ther. 292:2000;538-544
12. Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J. Clin. Neurophysiol. 9:1992;264-277
13. Gall C.M. Localization and seizure-induced alterations of opioid peptides and CCK in the hippocampus. NIDA Res. Monogr. 82:1988;12-32
14. Gall C., Lauterborn J., Burks D., Seroogy K. Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain. Brain Res. 403:1987;403-408
15. Giardino L., Bettelli C., Pozza M., Calza L. Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor. Brain Res. 824:1999;304-307
16. Hashimoto Y., Suemaru K., Yamamoto T., Kawakami K., Araki H., Gomita Y. Effect of immobilization stress on anticonvulsant actions and pharmacokinetics of zonisamide in mice. Pharmacol. Biochem. Behav. 68:2001;7-12
17. Hawranko A.A., Smith D.J. Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes. Brain Res. 824:1999;251-257
18. Hawranko A.A., Serafini M., Smith D.J. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors. Neurosci. Lett. 267:1999;101-104
19. Homayoun H., Khavandgar S., Dehpour A.R. The role of alpha2-adrenoceptors in the modulatory effects of morphine on seizure susceptibility in mice. Epilepsia. 43:2002;797-804
20. Homayoun H., Khavandgar S., Dehpour A.R. The involvement of endogenous opioids and nitricoxidegic pathway in the anticonvulsant effects of foot-shock stress in mice. Epilepsy Res. 49:2002;131-142
21. Idanpaan-Heikkila J.J., Perrot S., Guilbaud G., Kayser V. In mononeuropathic rats, the enhancement of morphine antinociception by L-365, 260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics. Eur. J. Pharmacol. 325:1997;155-164
22. Ingram S.M., Krause R.G., Baldino F. Jr., Skeen L.C., Lewis M.E. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J. Comp. Neurol. 287:1989;260-272
23. Kadar T., Penke B., Pesti A., Telegdy G. Multiple treatment potentiates the anticonvulsive activity of cholecystokinin octapeptides. Peptides. 6:1985;1009-1014
24. Kadar T., Borda L., Zarandi M., Penke B., Kovacs K., Telegdy G. Inhibition of electroshock-induced seizures by cholecystokinin-related peptides in mice. Acta Physiol. Hung. 69:1987;43-50
25. Kelly S.J., Franklin K.B. Role of peripheral and central opioid activity in analgesia induced by restraint stress. Life Sci. 41:1987;789-794
26. Lavigne G.J., Millington W.R., Mueller G.P. The CCK-A and CCK-B receptor antagonists, devazepide and L-365, 260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment. Neuropeptides. 21:1992;119-129
27. Legido A., Adler M.W., Karkanias C., Geller E.B., Bradley E., Greenstein J.I., et al. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors. Neuropeptides. 28:1995;107-113
28. Lewis J.W., Cannon J.T., Liebskind J.C. Opioid and nonopioid mechanisms of stress analgesia. Science. 208:1980;623-625
29. Madden J., Akil H., Patrick R.L., Barchas J.D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature. 265:1977;358-360
30. Oliverio A., Castellano C., Puglisi-Allegra S. Anticonvulsant effects of stress: role of endogenous opioids. Brain Res. 271:1983;193-195
31. Pavone F., Castellano C., Oliverio A. Strain-dependent effects of shock-induced release of opioids: dissociation between analgesia and behavioral seizures. Brain Res. 366:1986;326-328
32. Peričić D., Bujas M. Sex differences in bicuculline-induced convulsions: interactions with stress and ligands of benzodiazepine binding sites. Brain Res. 752:1997;279-284
33. Peričić D., Bujas M., Mirković K., Jazvinšćak M. The effects of adrenalectomy and gonadectomy on sex and stress-induced differences in bicuculline-induced convulsions. Exp. Brain Res. 129:1999;451-456
34. Peričić D., Švob D., Jazvinšćak M., Mirković K. Anticonvulsive effect of swim stress in mice. Pharmacol. Biochem. Behav. 66:2000;879-886
35. Peričić D., Jazvinšćak M., Švob D., Mirković K. Beta-1 adrenoceptor antagonists potentiate the anticonvulsive effect of swim stress in mice. Pharmacol. Biochem. Behav. 67:2000;507-510
36. Peričić D., Jazvinšćak M., Švob D., Mirković K. Swim stress alters the behavioural response of mice to GABA-related and some GABA-unrelated convulsions. Epilepsy Res. 43:2001;145-152
37. Pilcher C.W., Browne J.L. Effects of naloxone and Mr 1452 on stress-induced changes in nociception of different stimuli in rats. Life Sci. 33(Suppl. 1):1983;697-700
38. Rastegar H., Homayoun H., Afifi M., Rezayat M., Dehpour A.R. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur. Neuropsychopharmacol. 12:2002;111-118
39. Schwartz R.D., Wess M., Labarca R., Skolnick P., Paul S.M. Acute stress enhances the activity of the GABA receptor-gated chloride ion channel in brain. Brain Res. 411:1987;151-155
40. Shavit Y., Caldecott-Hazard S., Liebeskind J.C. Activating endogenous opioid systems by electroconvulsive shock or footshock stress inhibits recurrent kindled seizures in rats. Brain Res. 305:1984;203-207
41. Stengaard-Pedersen K., Larsson L.I. Localization and opiate receptor binding of enkephalin, CCK and ACTH/beta-endorphin in the rat central nervous system. Peptides. 2(Suppl. 1):1981;3-19
42. 3H] flunitrazepam cortical binding following stressful manipulations in rats. Brain Res. 189:1980;505-517
43. Suh H.H., Collins K.A., Tseng F. Intrathecal cholecystokinin octapeptide attenuates the analgesia and release of immunoreactive Met-enkephaline induced by intraventricular beta-endorphine in the rat. Neuropeptides. 21:1992;131-136
44. Watkins L.R., Kinschenck I.B., Kaufman E.F.S., Miller J., Frenk H., Mayer D.J. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res. 327:1985;181-190
45. Watkins L.R., Kinschenck I.B., Mayer D.J. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Science. 224:1985;395-396
46. Zarrindast M.R., Rezayat M. Caerulein changes morphine induced antinociception depending on pretreatment times. Gen. Pharmacol. 25:1994;311-316
47. Zelter G. Antagonism of cholecystokinin-like peptides, morphine or tetrodotoxine. Eur. J. Pharmacol. 60:1979;67-77
48. Zelter G. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide CCK-8. Neuropharmacology. 19:1980;415-422
49. Zetler G. Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepam. Eur. J. Pharmacol. 65:1980;297-300